Tandem Diabetes Care Inc TNDM Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-405

Price:

--
Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-145

Price:

$28.62
Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

405

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-407

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-113

Price:

$27.34
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

407

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-819

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-293

Price:

$27.34
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

819

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Vosseller Leigh

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-407

Price:

--

Filings by filing date

Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-405

Price:

--
Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-145

Price:

$28.62
Mar 15, 2024 (filed on Mar 19, 2024)

Insider Name:

Carpenter Rick

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

405

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-407

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-113

Price:

$27.34
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Morrison Susan

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

407

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-819

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-293

Price:

$27.34
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Sheridan John F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

819

Price:

--
Feb 27, 2024 (filed on Feb 29, 2024)

Insider Name:

Vosseller Leigh

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Unit

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-407

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	12400 High Bluff Drive SAN DIEGO CA 92130
Tel:	N/A
Website:	https://www.tandemdiabetes.com
IR:	See website

Key People

Leigh A. Vosseller Chief Financial Officer, Executive Vice President, Treasurer	Susan M. Morrison Executive Vice President, Chief Administrative Officer	Elizabeth A. Gasser Executive Vice President, Chief Strategy Officer
Brian B. Hansen Chief Commercial Officer, Executive Vice President	James A. Leal Senior Vice President - Operations	Rick Carpenter Chief Technical Officer

Business Overview

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Financial Overview

For the fiscal year ended 31 December 2023, Tandem Diabetes Care Inc revenues decreased 7% to $747.7M. Net loss increased from $94.6M to $222.6M. Revenues reflect Pump segment decrease of 13% to $374.3M. Higher net loss reflects Acquired in-process research and develop increase from $31M to $78.8M (expense), Research and development - Balancing val increase of 21% to $144.1M (expense).

Employees:	2,400 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$2,151M as of Dec 31, 2023
Annual revenue (TTM):	$747.72M as of Dec 31, 2023
EBITDA (TTM):	-$206.29M as of Dec 31, 2023
Net annual income (TTM):	-$222.61M as of Dec 31, 2023
Free cash flow (TTM):	-$83.41M as of Dec 31, 2023
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	65,631,041 as of Feb 16, 2024
Index Membership:	S&P 600 Small Cap
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization